IFNA1 and COVID-19: To gain further insight into the nature of IFN hyperactivity in DS, we interrogated datasets that our team generated via the COVIDome Project using a similar experimental pipeline, including identical whole blood transcriptome analysis of 73 hospitalized patients with COVID-19 versus 32 COVID-19–negative controls, none with DS (20–22).